2020 Episode 8 – Cardiorenal Protection in Patients with Diabetes and CKD
AHA, Know Diabetes by Heart
Listen to leading experts discuss the new Scientific Statement from the American Heart Association, “Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease,” where two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease.
Kidney & Diabetes
Rangaswami, Janani; Tuttle, Katherine; and Vaduganathan, Muthiah, "2020 Episode 8 – Cardiorenal Protection in Patients with Diabetes and CKD" (2020). Articles, Abstracts, and Reports. 3924.